C

CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765

Watchlist Manager
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Watchlist
Price: 40.44 CNY 1.61% Market Closed
Market Cap: 56.8B CNY

Intrinsic Value

The intrinsic value of one CSPC Innovation Pharmaceutical Co Ltd stock under the Base Case scenario is 31.94 CNY. Compared to the current market price of 40.44 CNY, CSPC Innovation Pharmaceutical Co Ltd is Overvalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
31.94 CNY
Overvaluation 21%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
CSPC Innovation Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CSPC Innovation Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CSPC Innovation Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
CN
Pharmaceuticals
Market Cap
56.8B CNY
IPO
Mar 22, 2019
CN
Pharmaceuticals
Market Cap
56.8B CNY
IPO
Mar 22, 2019
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about CSPC Innovation Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
CSPC Innovation Pharmaceutical Co Ltd

Current Assets 2.8B
Cash & Short-Term Investments 1.7B
Receivables 660.7m
Other Current Assets 457.1m
Non-Current Assets 3.2B
Long-Term Investments 264.4m
PP&E 2.7B
Intangibles 225.2m
Other Non-Current Assets 21.6m
Efficiency

Free Cash Flow Analysis
CSPC Innovation Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CSPC Innovation Pharmaceutical Co Ltd

Revenue
1.9B CNY
Cost of Revenue
-1.2B CNY
Gross Profit
744m CNY
Operating Expenses
-1.2B CNY
Operating Income
-447.9m CNY
Other Expenses
395.7m CNY
Net Income
-52.2m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

CSPC Innovation Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional Revenue Growth Forecast
Positive Gross Profit
Negative Net Income
50/100
Profitability
Score

CSPC Innovation Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CSPC Innovation Pharmaceutical Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
79/100
Solvency
Score

CSPC Innovation Pharmaceutical Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CSPC Innovation Pharmaceutical Co Ltd

Wall Street analysts forecast CSPC Innovation Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSPC Innovation Pharmaceutical Co Ltd is 48.45 CNY with a low forecast of 45.45 CNY and a high forecast of 52.5 CNY.

Lowest
Price Target
45.45 CNY
12% Upside
Average
Price Target
48.45 CNY
20% Upside
Highest
Price Target
52.5 CNY
30% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CSPC Innovation Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one CSPC Innovation Pharmaceutical Co Ltd stock?

The intrinsic value of one CSPC Innovation Pharmaceutical Co Ltd stock under the Base Case scenario is 31.94 CNY.

Is CSPC Innovation Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 40.44 CNY, CSPC Innovation Pharmaceutical Co Ltd is Overvalued by 21%.

Back to Top